Cannabidiol, by activating TRPV2, (i) triggers GSC differentiation, (ii) activates their autophagic processes, (iii) inhibits glioma stem cell proliferation, (iv) inhibits their clonogenic capability, and (v) abrogates their resistance to carmustine (BCNU) (Nabissi et al., 2015). This evidence concerns the gene TRPV2 and central nervous system cancer.